GE Healthcare Opens Training Center in South Korea
Demand for GE’s newest Fast Trak Center is expected to be high. During the past five years the domestic production of biopharmaceuticals in South Korea has grown 9%, and exports grew almost 34 percent between 2014 and 2015, from USD 589 million to USD 809 million(1). Songdo is already home to a number of leading South Korean biopharmaceutical companies, and excellent national and international transport links will enable GE customers from other parts of the country, and the wider Asia region, easy access to the services that the Center has to offer.
Kieran Murphy, President and CEO of GE Healthcare’s Life Sciences business, said: “We’re delighted to be investing in South Korea with our fifth global Fast Trak Center, which brings us closer to our customers in one of the world’s key bioprocessing hubs, enabling us to share our global knowledge and expertise at a local level. South Korea has some of the world’s most innovative biopharma companies, and we look forward to further supporting the growth of the industry here.”
The 2,200 m2 APAC Fast Trak Center in Songdo, South Korea adds to GE’s existing global network of Fast Trak Centers in the USA, Sweden, India, and China. The company also has satellite Fast Trak Centers in Turkey, Japan and Singapore. Worldwide, around 500 customers attend standard Fast Trak courses every year, with training available in local languages. In addition, there are customized courses that are built upon request and tailored according to customer needs.
Комментарии